S. Harbi

发表

NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AML

D. Olive, D. Blaise, A. Toubert, 2017, Oncoimmunology.

Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.

D. Blaise, Wang LiNing, R. Devillier, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The calcineurin inhibitor and the intensity of the conditioning regimen may affect the occurrence of polyomavirus-associated hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide

D. Blaise, R. Devillier, S. Harbi, 2017, Bone Marrow Transplantation.

Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia

S. Granjeaud, D. Olive, D. Blaise, 2015, Front. Immunol..

T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes

D. Blaise, C. Carlo-Stella, R. Devillier, 2016, Bone Marrow Transplantation.

Non-myeloablative conditioning regimen before T-cell replete haploidentical transplantation with post-transplant cyclophosphamide for advanced Hodgkin's and non-Hodgkin's lymphomas.

A. Santoro, D. Blaise, C. Carlo-Stella, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Checkpoint inhibition before haploidentical transplantation with posttransplant cyclophosphamide in Hodgkin lymphoma.

R. Bouabdallah, A. Santoro, D. Blaise, 2020, Blood advances.

Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

A. Santoro, D. Blaise, C. Carlo-Stella, 2018, Bone Marrow Transplantation.

Physicians Poster Sessions

R. Bouabdallah, D. Blaise, L. Giordano, 2016, Bone Marrow Transplantation.

Allogeneic stem cell transplantation in poor prognosis peripheral T-cell lymphoma: the impact of different donor type on outcome

R. Bouabdallah, A. Santoro, D. Blaise, 2020, Bone Marrow Transplantation.

Outcomes of Hodgkin lymphoma patients who relapse after allogeneic stem cell transplantation

R. Bouabdallah, A. Santoro, D. Blaise, 2016, Bone Marrow Transplantation.

The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide

A. Santoro, D. Blaise, C. Carlo-Stella, 2019, Bone Marrow Transplantation.

Tandem autologous-allogeneic stem cell transplantation as a feasible and effective procedure in high-risk lymphoma patients

R. Bouabdallah, A. Santoro, D. Blaise, 2015, Haematologica.

Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide

R. Fanin, P. Chiusolo, A. Santoro, 2022, Bone Marrow Transplantation.

Fatal acute respiratory distress syndrome with diffuse alveolar damage: donor lymphocyte infusion imputability?

D. Blaise, S. Harbi, V. Secq, 2016, European Respiratory Journal.

Posttransplantation cyclophosphamide vs. antithymocyte globulin as GVHD prophylaxis for mismatched unrelated hematopoietic stem cell transplantation

R. Bouabdallah, D. Blaise, R. Devillier, 2019, Bone Marrow Transplantation.

HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.

D. Blaise, R. Devillier, S. Harbi, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Successful treatment of post-transplant Epstein–Barr virus-related meningoencephalitis by intravenous rituximab monotherapy

D. Blaise, C. Oudin, R. Devillier, 2012, Leukemia & lymphoma.

Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years

D. Blaise, R. Touzani, R. Devillier, 2018, Bone Marrow Transplantation.

Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.

D. Blaise, R. Devillier, S. Harbi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m2 intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia

D. Blaise, R. Devillier, S. Harbi, 2016, Leukemia & lymphoma.

Reduced post-transplant cyclophosphamide doses in haploidentical hematopoietic cell transplantation for elderly patients with hematological malignancies

D. Blaise, M. Mohty, S. Ederhy, 2022, Bone Marrow Transplantation.

T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Bone Marrow Transplantation.

A matched‐pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution

D. Blaise, R. Devillier, S. Harbi, 2019, Transfusion.

Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

A. Santoro, D. Blaise, C. Carlo-Stella, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.

R. Bouabdallah, D. Blaise, R. Devillier, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide

R. Fanin, P. Chiusolo, A. Santoro, 2022, Bone Marrow Transplantation.

Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy.

R. Fanin, P. Chiusolo, A. Santoro, 2020, Blood advances.

R. Bouabdallah, A. Santoro, D. Blaise, 2015, Cancer.

Post-transplantation cyclophosphamide-based haploidentical versus Atg-based unrelated donor allogeneic stem cell transplantation for patients younger than 60 years with hematological malignancies: a single-center experience of 209 patients

R. Bouabdallah, D. Blaise, R. Devillier, 2018, Bone Marrow Transplantation.

The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

R. Bouabdallah, A. Santoro, D. Blaise, 2016, Bone Marrow Transplantation.

A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor

R. Bouabdallah, D. Blaise, D. Coso, 2014, American journal of hematology.

Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patients

R. Bouabdallah, D. Blaise, R. Devillier, 2019, Bone Marrow Transplantation.

Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.

R. Bouabdallah, A. Santoro, D. Blaise, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.

R. Bouabdallah, D. Blaise, C. Oudin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk Factors for early CMV reactivation and Impact of early CMV reactivation on Clinical Outcomes after T Cell-replete Haploidentical Transplantation with Post-transplant Cyclophosphamide.

A. Santoro, D. Blaise, L. Giordano, 2021, Transplantation and cellular therapy.

Safety of Anti-NKG2A Blocking Antibody Monalizumab As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Study

D. Olive, D. Blaise, A. Chretien, 2021, Blood.

Tacrolimus compared with cyclosporine A after haploidentical T-cell replete transplantation with post-infusion cyclophosphamide

D. Blaise, L. Giordano, C. Carlo-Stella, 2016, Bone Marrow Transplantation.

Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells

D. Blaise, R. Devillier, S. Harbi, 2018, British journal of haematology.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML

D. Blaise, R. Devillier, S. Harbi, 2017, Bone Marrow Transplantation.

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Bone Marrow Transplantation.

Comparison of Three Distinct Prophylactic Agents Against Invasive Fungal Infections in Patients Undergoing Haplo-identical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

R. Bouabdallah, A. Santoro, D. Blaise, 2015, Mediterranean journal of hematology and infectious diseases.

Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.

D. Blaise, R. Devillier, S. Harbi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T-Replete Haploidentical Allogeneic Transplantation Using Post-Transplantation Cyclophosphamide in Advanced Acute Myeloid Leukemia and Myelodysplastic Syndromes

A. Santoro, D. Blaise, R. Devillier, 2016 .

Low incidence of chronic GVHD after HLA‐haploidentical peripheral blood stem cell transplantation with post‐transplantation cyclophosphamide in older patients

D. Blaise, R. Devillier, S. Harbi, 2017, British journal of haematology.

Impact of CD34‐positive cell dose on outcome after peripheral blood stem cell allogeneic transplantation prepared with ATG‐based reduced intensity conditioning regimen

D. Blaise, R. Devillier, S. Harbi, 2017, American journal of hematology.

Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

P. Chevallier, A. Nagler, M. Mohty, 2023, Bone marrow transplantation.

Abnormal Proteins in Primary Breast Cancer Tissues from 25 Sudanese Patients

S. Harbi, J. Stanslas, A. O. Mohamed, 2008 .

D. Blaise, R. Devillier, S. Harbi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

R. Bouabdallah, A. Santoro, D. Blaise, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation

D. Blaise, R. Devillier, S. Harbi, 2023, Bone Marrow Transplantation.

R. Bouabdallah, D. Blaise, R. Devillier, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.